Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Oncolytics Biotech Inc. - Common Shares
(NQ:
ONCY
)
0.8859
+0.0493 (+5.89%)
Streaming Delayed Price
Updated: 4:00 PM EST, Feb 6, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Oncolytics Biotech Inc. - Common Shares
< Previous
1
2
3
Next >
ONCY Stock Rallies On Second Fast Track Designation For Experimental Cancer Drug
↗
February 04, 2026
The agency granted the designation to pelareorep in combination with bevacizumab and leucovorin, fluorouracil, irinotecan for the treatment of certain patients with metastatic colorectal cancer.
Via
Stocktwits
Top movers in Tuesday's after hours session
↗
January 20, 2026
Via
Chartmill
Curious about the stocks that are showing activity after the closing bell on Thursday?
↗
December 04, 2025
As the regular session of the US market concludes on Thursday, let's get an insight into the after-hours session and identify the stocks leading the pack in terms of gains and losses.
Via
Chartmill
12 Health Care Stocks Moving In Friday's Pre-Market Session
↗
October 10, 2025
Via
Benzinga
Earnings Scheduled For November 12, 2024
↗
November 12, 2024
Via
Benzinga
Earnings Preview: Oncolytics Biotech
↗
November 11, 2024
Via
Benzinga
Recap: Oncolytics Biotech Q4 Earnings
↗
March 07, 2024
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
↗
September 15, 2025
Via
Benzinga
Earnings Scheduled For August 8, 2025
↗
August 08, 2025
Via
Benzinga
What to Expect from Oncolytics Biotech's Earnings
↗
August 07, 2025
Via
Benzinga
A Preview Of Oncolytics Biotech's Earnings
↗
March 06, 2024
Via
Benzinga
Oncolytics Biotech's Earnings Outlook
↗
November 02, 2023
Via
Benzinga
Oncolytics Biotech's Earnings: A Preview
↗
August 11, 2023
Via
Benzinga
5 Analysts Have This to Say About Oncolytics Biotech
↗
June 29, 2023
Via
Benzinga
Why E2open Shares Are Trading Higher By 25%; Here Are 20 Stocks Moving Premarket
↗
May 27, 2025
Via
Benzinga
A Look at Oncolytics Biotech's Upcoming Earnings Report
↗
May 13, 2025
Via
Benzinga
What's going on in today's pre-market session
↗
April 17, 2025
Let's have a look at what is happening on the US markets before the opening bell on Thursday. Below you can find the top gainers and losers in today's pre-market session.
Via
Chartmill
Earnings Scheduled For March 7, 2025
↗
March 07, 2025
Via
Benzinga
Expert Ratings for Oncolytics Biotech
↗
May 26, 2023
Via
Benzinga
Earnings Scheduled For May 14, 2025
↗
May 14, 2025
Via
Benzinga
Extending Survival: Oncolytics Biotech's Pelareorep Shows Promise In Fighting Metastatic Breast Cancer
August 14, 2024
Extending Survival: Oncolytics Biotech's Pelareorep Shows Promise In Fighting Metastatic Breast Cancer
Via
News Direct
ONCY Stock Earnings: Oncolytics Biotech Beats EPS for Q1 2024
↗
May 09, 2024
ONCY stock results show that Oncolytics Biotech beat analyst estimates for earnings per share the first quarter of 2024.
Via
InvestorPlace
ONCY Stock Earnings: Oncolytics Biotech Beats EPS for Q4 2023
↗
March 07, 2024
ONCY stock results show that Oncolytics Biotech beat analyst estimates for earnings per share the fourth quarter of 2023.
Via
InvestorPlace
3 Under-$20 Stocks to Buy for Explosive Returns
↗
August 21, 2023
Are you looking to invest in stocks with massive potential? Here are three under $20 stocks to buy for explosive returns.
Via
InvestorPlace
Benzinga's Top Ratings Upgrades, Downgrades For May 24, 2023
↗
May 24, 2023
Via
Benzinga
Earnings Scheduled For March 7, 2024
↗
March 07, 2024
Companies Reporting Before The Bell • CI&T (NYSE:CINT) is estimated to report quarterly earnings at $0.06 per share on revenue of $106.08 million.
Via
Benzinga
Earnings Scheduled For November 3, 2023
↗
November 03, 2023
Companies Reporting Before The Bell • Arcutis Biotherapeutics (NASDAQ:ARQT) is expected to report quarterly loss at $0.86 per share on revenue of $32.83 million.
Via
Benzinga
Earnings Scheduled For August 14, 2023
↗
August 14, 2023
Companies Reporting Before The Bell • Safe & Green Holdings (NASDAQ:SGBX) is likely to report quarterly loss at $0.23 per share on revenue of $6.88 million.
Via
Benzinga
Why Avid Bioservices Shares Are Trading Lower By Over 14%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
↗
June 22, 2023
Gainers Aeglea BioTherapeutics, Inc. (NASDAQ: AGLE) shares climbed 422% to $0.5572 after the company announced acquisition of Spyre Therapeutics and concurrent oversubscribed $210 million private...
Via
Benzinga
Why Hibbett Shares Are Trading Lower By 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session
↗
May 26, 2023
Gainers Onfolio Holdings, Inc. (NASDAQ: ONFO) gained 73% to $2.02 after the company announced it completed development of a generative AI search tool.
Via
Benzinga
< Previous
1
2
3
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
